204 filings
8-K
OSIP
Osi Pharmaceuticals Inc
9 Jun 10
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
12:00am
8-K
OSIP
Osi Pharmaceuticals Inc
17 May 10
Companies enter into definitive merger agreement to combine to create a world- class oncology platform
12:00am
8-K
OSIP
Osi Pharmaceuticals Inc
22 Apr 10
OSI Pharmaceuticals, Inc. Announces First Quarter 2010 Financial Results
12:00am
8-K
OSIP
Osi Pharmaceuticals Inc
15 Apr 10
Other Events
12:00am
8-K
OSIP
Osi Pharmaceuticals Inc
6 Apr 10
Entry into a Material Definitive Agreement
12:00am
8-K
24yolz86
24 Mar 10
Other Events
12:00am
8-K
gb3044e94c9okfl7vq
3 Mar 10
Other Events
12:00am
8-K
3u551 u4ezn3ntsmg1
1 Mar 10
Other Events
12:00am
8-K/A
a72ra805nkmq0 oe
24 Feb 10
Results of Operations and Financial Condition
12:00am
8-K
ri23gs8 rc3misyq8
23 Feb 10
OSI Pharmaceuticals, Inc. Announces Year End 2009 Financial Results
12:00am
8-K
85azq um4y
19 Jan 10
Other Events
12:00am
8-K
8juiyxsgk
12 Jan 10
OSI Pharmaceuticals, Inc. Announces Fourth Quarter and 2009 Full Year Tarceva Sales
12:00am
8-K
vmz2 1honxyhmqk
8 Jan 10
Fda Advisory Committee Recommends Against Approving Tarceva for First-line Maintenance Use In Advanced Non-small Cell Lung Cancer
12:00am
8-K
frpg78r9mju ei8312
4 Dec 09
Other Events
12:00am
8-K
slnhphbs5p
21 Oct 09
OSI Pharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results
12:00am
8-K
mwpf0ds5zs5vpxi
15 Oct 09
Other Events
12:00am
8-K/A
7tseh6sd44dz6un81
24 Jul 09
Cost Associated with Exit or Disposal Activities
12:00am
8-K
jyns54 3vs
22 Jul 09
OSI Pharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
12:00am
8-K
s23y2egkqspyl
9 Jul 09
Osi Pharmaceuticals Announces Consolidation of U.s. Operations
12:00am
8-K
uwhzu bete
19 Jun 09
Other Events
12:00am